Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
IN
Intelligent Bio Solutions Inc. Common Stock
INBS
Volume
23.34K
Next Earnings
November 11th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
IN
INBS
IN
Intelligent Bio Solutions Inc. Common Stock
INBS
News
·
Intelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Mkt Cap
$5.0M
Volume
23.34K
Next Earnings
November 11th
Chart
Financials
Earnings
News
About
Insider
Filings
Intelligent Bio Solutions Announces Closing of $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Intelligent Bio Solutions Inc. (INBS) closed a $10.0 million private placement with two healthcare-focused institutional investors, issuing 2,298,850 shares of common stock at $4.35 per share along with Series K-1 and K-2 warrants. The company plans to use proceeds for working capital, FDA 510(k) submission for its Intelligent Fingerprinting Drug Screening System, and international market expansion.
GlobeNewswire Inc. · Jan 2, 2026
Stock Market Today: S&P 500, Dow Futures Gain On The First Trading Day Of 2026— Baidu, Rubico, Intelligent Bio Solutions In Focus
U.S. stock futures rose on the first trading day of 2026, with the S&P 500 and Nasdaq 100 gaining in premarket trading. Key movers included Baidu jumping 12.2% on a spinoff announcement, Rubico surging 16.8% following an acquisition deal, while Outlook Therapeutics plummeted 56.5% after an FDA rejection and Intelligent Bio Solutions dropped 23.4% on a private placement announcement. Analysts predict modest 3-5% gains for 2026 after a record-breaking 2025.
Benzinga · Jan 2, 2026
Intelligent Bio Solutions Announces $10.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Intelligent Bio Solutions Inc. (INBS) announced a $10.0 million private placement of 2,298,850 shares of common stock and warrants priced at $4.35 per share to two healthcare-focused institutional investors. The company plans to use net proceeds for working capital and general corporate purposes. Closing is expected on or about January 2, 2026, with Ladenburg Thalmann & Co. Inc. serving as the exclusive placement agent.
GlobeNewswire Inc. · Dec 31, 2025
Intelligent Bio Solutions Expands Global Reach with Multilingual Drug Screening System Upgrade
Intelligent Bio Solutions Inc. (INBS) announced plans to upgrade its Intelligent Fingerprinting Drug Screening System to support multiple languages, making it accessible to over 4 billion users worldwide. This move aligns with the company's strategic global expansion goals, including a planned entry into the US market in 2025.
GlobeNewswire Inc. · Jan 31, 2025
Intelligent Bio Solutions Adds Quantum TM to 400+ Account Portfolio Utilizing Breakthrough Fingerprint Drug Testing
Intelligent Bio Solutions Inc. (INBS) announced that Quantum Traffic Management (Quantum TM), a UK-based traffic management provider, has adopted INBS' Intelligent Fingerprinting Drug Testing Solution across its 10 nationwide sites. The fingerprint-based system enables Quantum TM to conduct on-the-spot drug screening in-house, improving testing efficiency and productivity.
GlobeNewswire Inc. · Jan 29, 2025
Intelligent Bio Solutions Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek
Intelligent Bio Solutions Inc. (INBS) announced that global engineering leader Pyrotek Pty Ltd has adopted its non-invasive drug screening solution, which will enhance workplace safety and productivity.
GlobeNewswire Inc. · Oct 14, 2024
Intelligent Bio Solutions Inc. Announces Board Changes - Investing.com
Intelligent Bio Solutions Inc. announced changes to its Board of Directors following the passing of board member Lawrence Fisher. The company reduced the board size from five to four members and appointed new members to the Audit and Compensation Committees.
Investing.com · Jul 22, 2024
Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results
NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful completion of the in-clinic portion of its pharmacokinetic (PK) study, a core component of the Company's clinical study plan for its 510(k) pathway for regulatory approval.
GlobeNewswire Inc. · Jun 28, 2024
Intelligent Bio Solutions Expands Presence in the UK Retail Sector with Major Account Acquisitions
NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the expansion of its customer network within the UK retail sector. This includes the adoption of INBS' Intelligent Fingerprinting Drug Screening System by three prominent UK retailers, among the largest and most recognized in the country.
GlobeNewswire Inc. · Jun 27, 2024
Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology
Pharmacokinetic study is key step on path to expansion into US market Pharmacokinetic study is key step on path to expansion into US market
GlobeNewswire Inc. · Jun 18, 2024
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
IN
INBS
Intelligent Bio Solutions Inc. Common Stock
Buy
Sell
Market
Limit
Soon
INBS
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any INBS yet.
Related Tickers
Earnings